|
Volumn 19, Issue 2, 2007, Pages 226-227
|
Anti-ischemic effects of sildenafil, vardenafil and tadalafil in heart
|
Author keywords
[No Author keywords available]
|
Indexed keywords
PHOSPHODIESTERASE V INHIBITOR;
SILDENAFIL;
TADALAFIL;
VARDENAFIL;
DOG;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG POTENCY;
ERECTILE DYSFUNCTION;
HEART INFARCTION;
HEART INFARCTION SIZE;
HEART MUSCLE ISCHEMIA;
HEART MUSCLE REPERFUSION;
HEART PROTECTION;
IC 50;
LETTER;
MEAN ARTERIAL PRESSURE;
NONHUMAN;
PRIORITY JOURNAL;
PULMONARY HYPERTENSION;
RABBIT;
REPERFUSION INJURY;
THERAPY EFFECT;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
ANIMALS;
CARBOLINES;
CARDIOTONIC AGENTS;
IMIDAZOLES;
MALE;
MYOCARDIAL INFARCTION;
MYOCARDIAL ISCHEMIA;
MYOCARDIAL REPERFUSION INJURY;
PHOSPHODIESTERASE INHIBITORS;
PIPERAZINES;
PURINES;
RABBITS;
RATS;
SPECIES SPECIFICITY;
SULFONES;
TRIAZINES;
|
EID: 33847365760
PISSN: 09559930
EISSN: 14765489
Source Type: Journal
DOI: 10.1038/sj.ijir.3901533 Document Type: Letter |
Times cited : (12)
|
References (6)
|